|
Volumn 33, Issue 5, 2016, Pages 381-383
|
Postanaesthesia pulmonary complications after use of muscle relaxants in Europe
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MUSCLE RELAXANT AGENT;
ASPIRATION PNEUMONIA;
ATELECTASIS;
BRONCHOSPASM;
EUROPE;
GENERAL ANESTHESIA;
HOSPITALIZATION;
HUMAN;
LETTER;
LUNG DISEASE;
LUNG INFECTION;
LUNG INFILTRATE;
MORTALITY;
NEUROMUSCULAR FUNCTION;
NEUROMUSCULAR MONITORING;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PULMONARY COMPLICATION;
REGIONAL ANESTHESIA;
SAMPLE SIZE;
ADVERSE EFFECTS;
CHEMICALLY INDUCED;
CLINICAL TRIAL;
INCIDENCE;
LUNG DISEASES;
METHODOLOGY;
MULTICENTER STUDY;
NEUROMUSCULAR BLOCKING;
RISK ASSESSMENT;
RISK FACTOR;
TIME FACTOR;
ANESTHESIA, GENERAL;
EUROPE;
HUMANS;
INCIDENCE;
LUNG DISEASES;
NEUROMUSCULAR AGENTS;
NEUROMUSCULAR BLOCKADE;
RESEARCH DESIGN;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
|
EID: 84963828225
PISSN: 02650215
EISSN: 13652346
Source Type: Journal
DOI: 10.1097/EJA.0000000000000363 Document Type: Letter |
Times cited : (8)
|
References (7)
|